STAT3 and cervical cancer: In cervical cancer, clinical trials are required to find out whether the use of these molecules can have a positive effect on the overall and disease-free survival of patients, in addition to evaluating the toxicity of these treatments, as the reports indicate that STAT3 inhibitors are highly toxic.